Cargando…
Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies
Aberrant DNA methylation plays a pivotal role in tumor development and progression. DNA hypomethylating agents (HMA) constitute a class of drugs which are able to reverse DNA methylation, thereby triggering the re-programming of tumor cells. The first-generation HMA azacitidine and decitabine have n...
Autores principales: | Stomper, Julia, Rotondo, John Charles, Greve, Gabriele, Lübbert, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257497/ https://www.ncbi.nlm.nih.gov/pubmed/33958699 http://dx.doi.org/10.1038/s41375-021-01218-0 |
Ejemplares similares
-
HMA6 and HMA8 are two chloroplast Cu(+)-ATPases with different enzymatic properties
por: Sautron, Emeline, et al.
Publicado: (2015) -
Expression of HMA4 cDNAs of the zinc hyperaccumulator Noccaea caerulescens from endogenous NcHMA4 promoters does not complement the zinc-deficiency phenotype of the Arabidopsis thaliana hma2hma4 double mutant
por: Iqbal, Mazhar, et al.
Publicado: (2013) -
Determination the Usefulness of AhHMA4p1::AhHMA4 Expression in Biofortification Strategies
por: Weremczuk, Aleksandra, et al.
Publicado: (2016) -
P706: RESISTANCE TO HYPOMETHYLATING AGENTS (HMA) IN HIGH-RISKMYELODYSPLASTIC SYNDROME (HR-MDS): THE ROLE OF THE ADENOSINEDEAMINASE ACTING ON RNA 1 (ADAR1) ENZYME
por: Dimitriou, Despoina, et al.
Publicado: (2023) -
Effective reduction of cadmium accumulation in rice grain by expressing OsHMA3 under the control of the OsHMA2 promoter
por: Shao, Ji Feng, et al.
Publicado: (2018)